Literature DB >> 23494537

Appearance of attenuated intestinal polyposis during chronic non-steroidal anti-inflammatory drugs use.

Hugh James Freeman1.   

Abstract

Aspirin and non-steroidal anti-inflammatory drugs (NSAIDS) may prevent sporadic colonic neoplasia and reduce the polyp burden in familial adenomatous polyposis. A 41-year-old pharmacologist with no family history of intestinal polyps or cancer chronically consumed daily aspirin and other non-steroidal anti-inflammatory drugs for decades despite recurrent and multiple gastric ulcers. A cancerous polyp in the colon was endoscopically resected. Over the next 2 decades, almost 50 adenomatous polyps were removed from the rest of his colon and duodenum, typical of an attenuated form of adenomatous polyposis. Chronic and habitual use of aspirin or NSAIDS may have important significance in delaying the appearance of adenomas. The observations here emphasize the important implications for clinical risk assessment in screening programs designed to detect or prevent colon cancer.

Entities:  

Keywords:  Aspirin; Attenuated polyposis; Chemoprevention of colon cancer; Colon adenoma; Colon cancer; Duodenal adenoma; Non-steroidal anti-inflammatory drugs

Year:  2012        PMID: 23494537      PMCID: PMC3596514          DOI: 10.4292/wjgpt.v3.i6.100

Source DB:  PubMed          Journal:  World J Gastrointest Pharmacol Ther        ISSN: 2150-5349


  11 in total

1.  MYH-associated disease: attenuated adenomatous polyposis of the colon is only part of the story.

Authors:  Jonathan P Terdiman
Journal:  Gastroenterology       Date:  2009-10-29       Impact factor: 22.682

2.  Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.

Authors:  Elizabeth L R Barry; John A Baron; Shubha Bhat; Maria V Grau; Carol A Burke; Robert S Sandler; Dennis J Ahnen; Robert W Haile; Thomas G O'Brien
Journal:  J Natl Cancer Inst       Date:  2006-10-18       Impact factor: 13.506

Review 3.  Hereditary and familial colon cancer.

Authors:  Kory W Jasperson; Thérèse M Tuohy; Deborah W Neklason; Randall W Burt
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

Review 4.  Primary prevention of colorectal cancer.

Authors:  Andrew T Chan; Edward L Giovannucci
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

5.  Polymorphisms and colorectal tumor risk.

Authors:  R S Houlston; I P Tomlinson
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

Review 6.  Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.

Authors:  Alaa Rostom; Catherine Dubé; Gabriela Lewin; Alexander Tsertsvadze; Nicholas Barrowman; Catherine Code; Margaret Sampson; David Moher
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

Review 7.  The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.

Authors:  Catherine Dubé; Alaa Rostom; Gabriela Lewin; Alexander Tsertsvadze; Nicholas Barrowman; Catherine Code; Margaret Sampson; David Moher
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

8.  Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study.

Authors:  Marcia Cruz-Correa; Linda M Hylind; Katherine E Romans; Susan V Booker; Francis M Giardiello
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

9.  Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

Authors:  Bernard F Cole; Richard F Logan; Susan Halabi; Robert Benamouzig; Robert S Sandler; Matthew J Grainge; Stanislas Chaussade; John A Baron
Journal:  J Natl Cancer Inst       Date:  2009-02-10       Impact factor: 13.506

Review 10.  Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.

Authors:  Jack Cuzick; Florian Otto; John A Baron; Powel H Brown; John Burn; Peter Greenwald; Janusz Jankowski; Carlo La Vecchia; Frank Meyskens; Hans Jörg Senn; Michael Thun
Journal:  Lancet Oncol       Date:  2009-05       Impact factor: 41.316

View more
  1 in total

Review 1.  Duodenal adenoma surveillance in patients with familial adenomatous polyposis.

Authors:  Fábio Guilherme Campos; Marianny Sulbaran; Adriana Vaz Safatle-Ribeiro; Carlos Augusto Real Martinez
Journal:  World J Gastrointest Endosc       Date:  2015-08-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.